Until Labs
Until Labs is a biotechnology company focused on developing advanced cryopreservation technologies to pause biological time. The company specializes in creating perfusion hardware, cryoprotective agents, and rewarming infrastructure to enable the reversible cryopreservation of biological systems, particularly donor organs. By preserving organs at low temperatures for indefinite storage and rewarming them for transplant, Until Labs aims to improve organ matching and reduce organ wastage, ultimately enhancing the outcomes for transplant patients.
Leadership & Board
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $58M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $58M
- Latest Funding Round
- Series A
- Post-Money Valuation
- ―
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 22, 2025 | Series A | $58.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Lux Capital | Series A |
| Founders Fund | Series A |
| Field Ventures | Series A |
Similar Companies
A snapshot of private companies similar to Until Labs, helping you discover and navigate related company profiles.
Related News and Analysis
